Codeine-Guaifenesin
- Product NDC
- 68071-5173
- 11-digit product format
- 680715173
- Labeler code
- 68071
- Product ID
- 68071-5173_1b56a7bc-e859-d8c7-e063-6294a90a5ee1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Codeine Phosphate and Guaifenesin
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-04-01
- Substance
- CODEINE PHOSPHATE; GUAIFENESIN
- Active strength
- 10; 100 mg/5mL; mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 68071-5173-4 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 68071-5173-4 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 68071-5173-4 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Codeine-Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CODEINE PHOSPHATE | 10 mg/5mL |
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| GSL05Y1MN6 | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995868 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9e691264-d48a-6b48-e053-2995a90a9352 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-5173-4 | 2024-06-25 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
| 68071-5173-4 | 2023-01-30 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5173-4 | Codeine-Guaifenesin | 120 mL in 1 BOTTLE | SOLUTION | 120 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5173 | CODEINE-GUAIFENESIN (CODEINE PHOSPHATE AND GUAIFENESIN) SOLUTION [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240627_9e691264-d48a-6b48-e053-2995a90a9352.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 0faa3592-4d56-4645-9a0e-066e0bdfebb6 | 2024-04-05 | Warnings | M013 |
| Pain Relief Childrens Dye Free | ACETAMINOPHEN | H E B | 3f9beeeb-5e27-4b81-a647-20e65f0e9fc9 | 2024-04-03 | Warnings | M013 |
| Low Dose Aspirin | ASPIRIN | H E B | edb321dd-e5cb-4031-a8a8-efce9e86fe16 | 2024-04-03 | Warnings | M013 |
| Childrens Pain Relief | ACETAMINOPHEN | H E B | a0c0277e-50aa-4328-8f93-ab20c6176b2b | 2024-04-03 | Warnings | M013 |
| Regular Strength Enteric coated aspirin | ASPIRIN | Bryant Ranch Prepack | bda805ab-7f37-405d-a144-4e06ad9a29a1 | 2024-04-03 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Family Dollar (FAMILY WELLNESS) | 650cb15e-c448-4df3-b0f8-4398be05d841 | 2024-03-27 | Warnings | M013 |
| Good Sense Effervescent Pain Relief | ASPIRIN | Perrigo Direct, Inc. | 103027a7-2f0e-8d8c-e063-6294a90aedc7 | 2024-03-26 | Warnings | M013 |
| rugby infants acetaminophen | ACETAMINOPHEN | Rugby Laboratories | 8aa9ac68-ca61-4163-a876-52034138c1ea | 2024-03-25 | Warnings | M013 |
| Equate Pain Reliever Acetaminophen for Adults 250 mg | ACETAMINOPHEN | Walmart Inc | 08a18481-f029-f01f-e063-6294a90aac65 | 2024-03-21 | Warnings | M013 |
| Equate Pain Reliever Acetaminophen for Adults 250 mg | ACETAMINOPHEN | Walmart Inc | 0d106fa2-2a77-deb2-e063-6394a90a2dac | 2024-03-21 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 872c5220-a379-4dc1-b99c-f11ebb82db35 | 2024-03-19 | Warnings | M013 |
| Pain Reliever PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 79886972-47a4-44c5-a131-1a691a328103 | 2024-03-19 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 5ffcc78d-9163-4cb4-8811-ae9f0142806a | 2024-03-18 | Warnings | M013 |
| ASPIRIN LOW DOSE CHEWABLE ORANGE PAIN RELIEVER | ASPIRIN LOW DOSE CHEWABLE ORANGE PAIN RELIEVER | HF Acquisition Co LLC, DBA HealthFirst | 13e621dc-b2b4-98fd-e063-6394a90acc75 | 2024-03-17 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | CVS PHARMACY, INC | 097a9c98-a092-400d-9600-6797b0b9a50c | 2024-03-15 | Warnings | M013 |
| Excedrin PM Triple Action Caplets and Excedrin Tension Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, AND DIPHENHYDRAMINE CITRATE | Haleon US Holdings LLC | 978a9d27-6d41-42cb-a193-11314923d2ac | 2024-03-14 | Warnings | M013 |
| Excedrin PM Triple Action Caplets | ACETAMINOPHEN, ASPIRIN (NSAID) AND DIPHENHYDRAMINE CITRATE | Haleon US Holdings LLC | b3812d27-40af-40d7-864a-dfa4ae34cb9e | 2024-03-14 | Warnings | M013 |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 691b754c-bafc-47e2-a322-cf56245c01f6 | 2024-03-14 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | CVS PHARMACY, INC | fdc80b2a-d7c1-4b3d-9a9b-28182c6320de | 2024-03-14 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | QUALITY CHOICE (Chain Drug Marketing Association) | 2cde052d-22a4-470f-8d6a-7c17061b8ac8 | 2024-03-14 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995868 | codeine phosphate 10 MG / guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 10 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-5173-4 | 68071517304 | 120 mL in 1 BOTTLE (68071-5173-4) | 120 ml | 2020-02-12 | 0000-00-00 | No | No | Current |